Study: CBD Inhibits Brain Cancer Through Multiple Pathways

Investigators from Spain, Italy and Canada now have evidence that cannabidiol (CBD) – a non-psychoactive chemical found in marijuana – exerts a combination of anti-cancer effects at the molecular level.Medical-Marijuana

Published last month in the open-access journal PLOS One, the results provide “new insights into the antitumor action of CBD, showing that this cannabinoid affects multiple tumoral features and molecular pathways,” write the authors, who conducted experiments using CBD and glioma cell cultures.

Led by Paola Massi, PhD from the University of Milan, the team concludes that CBD could offer an effective treatment for brain cancer – without side effects.

“As CBD is a non-psychoactive phytocannabinoid that appears to be devoid of side effects, our results support its exploitation as an effective anti-cancer drug in the management of gliomas.”

While marijuana’s cancer-fighting potential is not a new discovery, interest has grown in recent years. Earlier this month, the drug company GW Pharmaceuticals announced the start of the first clinical trials involving cannabis-based medicine as a cancer therapy.

Dr. Massi and her colleagues have also conducted a number of earlier pre-clinical studies on cannabinoids and cancer, with funding from GW Pharmaceuticals.

Read more via Study: CBD Inhibits Brain Cancer Through Multiple Pathways – Leaf Science.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s